Calumet Specialty Products Partners (CLMT)
(Delayed Data from NSDQ)
$15.58 USD
-0.62 (-3.83%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $15.57 -0.01 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Calumet Specialty Products Partners, LP falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 8 | 35 | 38 | 109 | 19 |
Receivables | 286 | 268 | 253 | 160 | 189 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 439 | 498 | 327 | 255 | 293 |
Other Current Assets | 61 | 19 | 15 | 10 | 12 |
Total Current Assets | 795 | 820 | 633 | 535 | 512 |
Net Property & Equipment | 1,506 | 1,482 | 950 | 920 | 974 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 202 | 209 | 219 | 231 | 243 |
Deposits & Other Assets | 134 | 123 | 169 | 37 | 37 |
Total Assets | 2,751 | 2,742 | 2,128 | 1,808 | 1,858 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 322 | 442 | 301 | 179 | 230 |
Current Portion Long-Term Debt | 333 | 419 | 208 | 3 | 2 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 136 | 128 | 121 | 59 | 68 |
Income Taxes Payable | 14 | 10 | 12 | 10 | 12 |
Other Current Liabilities | 233 | 283 | 193 | 252 | 193 |
Total Current Liabilities | 1,113 | 1,352 | 900 | 545 | 565 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,830 | 1,617 | 1,498 | 1,319 | 1,210 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 260 | 273 | 23 | 28 | 29 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,242 | 3,280 | 2,513 | 1,937 | 1,836 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 1 | 1 | 4 | 9 | 12 |
Common Stock (Par) | -484 | -530 | -379 | -125 | 20 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 |
Other Equity | -7 | -8 | -10 | -12 | -11 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -490 | -538 | -385 | -129 | 22 |
Total Liabilities & Shareholder's Equity | 2,751 | 2,742 | 2,128 | 1,808 | 1,858 |
Total Common Equity | -492 | -538 | -389 | -138 | 10 |
Shares Outstanding | 79.90 | 79.10 | 78.60 | 78.00 | 77.50 |
Book Value Per Share | -6.15 | -6.80 | -4.95 | -1.76 | 0.12 |
Fiscal Year End for Calumet Specialty Products Partners, LP falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 8 | 14 | 36 | 11 |
Receivables | NA | 286 | 348 | 315 | 297 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 439 | 448 | 440 | 455 |
Other Current Assets | NA | 61 | 54 | 56 | 37 |
Total Current Assets | NA | 795 | 863 | 847 | 800 |
Net Property & Equipment | NA | 1,506 | 1,527 | 1,536 | 1,543 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 202 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 134 | 415 | 420 | 421 |
Total Assets | NA | 2,751 | 2,805 | 2,804 | 2,765 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 322 | 342 | 278 | 394 |
Current Portion Long-Term Debt | NA | 333 | 531 | 497 | 440 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 136 | 124 | 110 | 115 |
Income Taxes Payable | NA | 14 | 0 | 0 | 0 |
Other Current Liabilities | NA | 233 | 323 | 313 | 317 |
Total Current Liabilities | NA | 1,113 | 1,320 | 1,198 | 1,266 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 1,830 | 1,625 | 1,849 | 1,722 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 308 | 304 | 303 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 3,242 | 3,252 | 3,352 | 3,291 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 1 | 3 | 1 | 1 |
Common Stock (Par) | NA | -484 | -442 | -540 | -519 |
Capital Surplus | NA | 0 | 0 | 0 | 0 |
Retained Earnings | NA | 0 | 0 | 0 | 0 |
Other Equity | NA | -7 | -8 | -8 | -8 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -490 | -448 | -548 | -526 |
Total Liabilities & Shareholder's Equity | NA | 2,751 | 2,805 | 2,804 | 2,765 |
Total Common Equity | 0 | -492 | -450 | -549 | -527 |
Shares Outstanding | 80.20 | 79.90 | 79.90 | 79.90 | 79.80 |
Book Value Per Share | 0.00 | -6.15 | -5.64 | -6.86 | -6.61 |